JNJ vs PG
Johnson & Johnson vs The Procter & Gamble Company · Updated Mar 28, 2026
JNJ — 17 winsPG — 6 wins
Price Performance
JNJ +46.88%PG -15.07%
Performance
| JNJ | PG | |
|---|---|---|
| 1 Month | -1.52% | -13.19% |
| 3 Months | +15.40% | -0.38% |
| 6 Months | +34.91% | -6.79% |
| YTD | +15.86% | -0.81% |
| 1 Year | +48.27% | -14.19% |
| 3 Year | +45.35% | +11.63% |
| 5 Year | +67.20% | +6.44% |
Yearly Returns
| YTD | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| JNJ | +16.0% | +43.7% | -9.6% | -12.0% | +3.0% | +9.3% | +7.8% | +14.2% | -7.3% | +20.6% | +14.7% | -1.7% |
| PG | +0.7% | -13.7% | +12.7% | -3.3% | -7.0% | +18.7% | +12.8% | +36.8% | +1.4% | +9.1% | +7.3% | -12.2% |
Valuation
| JNJ | PG | |
|---|---|---|
| P/E Ratio | 21.72 | 21.06 |
| Forward P/E | 20.58 | 20.85 |
| PEG Ratio | 2.47 | 4.00 |
| P/S Ratio | 6.02 | 3.96 |
| P/B Ratio | 6.96 | 6.33 |
| EV/EBITDA | 14.78 | 15.38 |
Financials
| JNJ | PG | |
|---|---|---|
| EPS (TTM) | $11.04 | $6.75 |
| Gross Margin | +67.56% | +51.22% |
| Operating Margin | +20.22% | +24.16% |
| Net Margin | +20.83% | +19.50% |
| ROE | +32.87% | +30.99% |
| ROA | +13.46% | +12.98% |
| Debt/Equity | 0.51 | 0.69 |
Growth
| JNJ | PG | |
|---|---|---|
| Revenue Growth YoY | +9.08% | +1.49% |
| Revenue Growth QoQ | +2.38% | -0.80% |
| EPS Growth YoY | +48.23% | -5.32% |
| EPS Growth QoQ | -1.42% | -8.72% |
Technical
| JNJ | PG | |
|---|---|---|
| RSI (14) | 49.94 | 30.04 |
| % From 20-Day SMA | -0.41% | -5.57% |
| % From 50-Day SMA | +1.21% | -7.13% |
| % From 200-Day SMA | +21.93% | -6.72% |
| % From 52-Week High | -4.74% | -18.12% |
| % From 52-Week Low | +69.46% | +3.29% |
Analyst Ratings
JNJ
Buy(37 analysts)
Strong SellHoldStrong Buy
Price Target
$228.73
-2.73% upside
PG
Buy(15 analysts)
Strong SellHoldStrong Buy
Price Target
$167.67
+15.79% upside
Overview
| JNJ | PG | |
|---|---|---|
| Sector | Healthcare | Consumer Defensive |
| Industry | Drug Manufacturers - General | Household & Personal Products |
| Exchange | NYSE | NYSE |
| Market Cap | $567.22B | $337.46B |
| Shares Outstanding | 2.41B | 2.34B |
| Avg Volume (10D) | 7.97M | 13.55M |
| Dividend Yield | 2.21% | 2.93% |
Frequently Asked Questions
Is JNJ or PG a better buy right now?
Based on 23 comparable metrics, JNJ leads in 17 categories while PG leads in 6. JNJ has a consensus analyst rating with 37 analysts covering the stock. Neither stock should be purchased based on a single comparison — consider your investment goals and risk tolerance.
Which stock has better performance, JNJ or PG?
Over the past year, JNJ returned +48.27% compared to PG's -14.19%. In the short term (1 month), JNJ returned -1.52% vs PG's -13.19%.
Is JNJ or PG more expensive?
JNJ trades at a P/E of 21.72 compared to PG's 21.06. On a price-to-sales basis, JNJ trades at 6.02x vs PG's 3.96x. Forward P/E: JNJ at 20.58 vs PG at 20.85.
Which stock has higher growth, JNJ or PG?
JNJ's revenue grew +9.08% year-over-year compared to PG's +1.49%. EPS growth: JNJ at +48.23% vs PG at -5.32%.
Do JNJ and PG pay dividends?
JNJ pays a dividend with a yield of 2.21%. PG pays a dividend with a yield of 2.93%.
Which stock do analysts prefer, JNJ or PG?
JNJ has 37 analysts with a target price of $228.73 (-2.73% upside). PG has 15 analysts with a target of $167.67 (+15.79% upside).
Data updated daily. All comparisons based on latest available market data. Not investment advice.